Human papillomavirus shows highly variable prevalence in esophageal squamous cell carcinoma and no significant correlation to p16INK4a overexpression: A systematic review

Journal of Thoracic Oncology

Volumn 9, Issue 6, 2014, Pages 865-871

  Michaelsen, Sanne Høxbroe ^a   Larsen, Christian Grønhøj ^a   Von Buchwald, Christian ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Esophageal squamous cell carcinoma; Human papillomavirus

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA; BIOLOGICAL MARKER;

ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; NONHUMAN; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; WART VIRUS; CHEMISTRY; COMPLICATION; ESOPHAGUS TUMOR; GENETICS; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; SQUAMOUS CELL CARCINOMA; VIROLOGY;

BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; ESOPHAGEAL NEOPLASMS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE;

EID: 84901595219     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000166     Document Type: Article

References (26)

1. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265. (Pubitemid 34293391)
2. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-720. (Pubitemid 30365531)
3. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
4. van Monsjou HS, van Velthuysen ML, van den Brekel MW, Jordanova ES, Melief CJ, Balm AJ. Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer 2012;130:1806-1812.
5. Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 2007;17:2-9. (Pubitemid 44918357)
6. Syrjänen KJ. HPV infections and lung cancer. J Clin Pathol 2002;55:885-891. (Pubitemid 35454486)
7. Gillison ML, Shah KV. Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 2003;57-65.
8. Liang C, Marsit CJ, McClean MD, et al. Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res 2012;72:5004-5013.
9. Lewis JS, Jr. p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol 2012;6 (Suppl 1):S75-S82.
10. Khleif SN, DeGregori J, Yee CL, et al. Inhibition of cyclin D- CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci U S A 1996;93: 4350-4354.
11. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-284. (Pubitemid 32225381)
12. Ding GC, Ren JL, Chang FB, et al. Human papillomavirus DNA and P16(INK4A) expression in concurrent esophageal and gastric cardia cancers. World J Gastroenterol 2010;16:5901-5906.
13. Herbster S, Ferraro CT, Koff NK, et al. HPV infection in Brazilian patients with esophageal squamous cell carcinoma: interpopulational differences, lack of correlation with surrogate markers and clinicopathological parameters. Cancer Lett 2012;326:52-58.
14. Koshiol J, Wei WQ, Kreimer AR, et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer 2010;127:93-100.
15. Shuyama K, Castillo A, Aguayo F, et al. Human papillomavirus in highand low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer 2007;96:1554-1559. (Pubitemid 46762959)
16. Castillo A, Koriyama C, Higashi M, et al. Human papillomavirus in upper digestive tract tumors from three countries. World J Gastroenterol 2011;17:5295-5304.
17. Löfdahl HE, Du J, Näsman A, et al. Prevalence of human papillomavirus (HPV) in oesophageal squamous cell carcinoma in relation to anatomical site of the tumour. PLoS One 2012;7:e46538.
18. Vaiphei K, Kochhar R, Bhardawaj S, Dutta U, Singh K. High prevalence of human papillomavirus in esophageal squamous cell carcinoma: a study in paired samples. Dis Esophagus 2013;26:282-287.
19. Bellizzi AM, Woodford RL, Moskaluk CA, Jones DR, Kozower BD, Stelow EB. Basaloid squamous cell carcinoma of the esophagus: assessment for high-risk human papillomavirus and related molecular markers. Am J Surg Pathol 2009;33:1608-1614.
20. Malik SM, Nevin DT, Cohen S, Hunt JL, Palazzo JP. Assessment of immunohistochemistry for p16INK4 and high-risk HPV DNA by in situ hybridization in esophageal squamous cell carcinoma. Int J Surg Pathol 2011;19:31-34.
21. Castillo A, Aguayo F, Koriyama C, et al. Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile. World J Gastroenterol 2006;12:6188-6192. (Pubitemid 44688170)
22. Antonsson A, Nancarrow DJ, Brown IS, et al.; Australian Cancer Study. High-risk human papillomavirus in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2010;19:2080-2087.
23. Doxtader EE, Katzenstein AL. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases. Hum Pathol 2012;43:327-332.
24. Beniston RG, Morgan IM, O'Brien V, Campo MS. Quercetin, E7 and p53 in papillomavirus oncogenic cell transformation. Carcinogenesis 2001;22:1069-1076. (Pubitemid 32633606)
25. Campo MS, Moar MH, Sartirana ML, Kennedy IM, Jarrett WF. The presence of bovine papillomavirus type 4 DNA is not required for the progression to, or the maintenance of, the malignant state in cancers of the alimentary canal in cattle. EMBO J 1985;4:1819-1825.
26. Tokugawa T, Sugihara H, Tani T, Hattori T. Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Cancer Res 2002;62:4938-4944. (Pubitemid 34984417)